↓ Skip to main content

The Role of Statins in Prevention of Preeclampsia: A Promise for the Future?

Overview of attention for article published in Frontiers in Pharmacology, May 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
93 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Role of Statins in Prevention of Preeclampsia: A Promise for the Future?
Published in
Frontiers in Pharmacology, May 2017
DOI 10.3389/fphar.2017.00247
Pubmed ID
Authors

Vasiliki Katsi, Georgios Georgountzos, Manolis S. Kallistratos, Ioannis Zerdes, Thomas Makris, Athanasios J. Manolis, Petros Nihoyannopoulos, Dimitris Tousoulis

Abstract

Preeclampsia has been linked to high morbidity and mortality during pregnancy. However, no efficient pharmacological options for the prevention of this condition are currently available. Preeclampsia is thought to share several pathophysiologic mechanisms with cardiovascular disease, which has led to investigations for the potential role of statins (HMG CoA reductase inhibitors) in its prevention and early management. Pravastatin seems to have a safer pharmacokinetic profile compared to other statins, however, the existing preclinical evidence for its effectiveness in preeclampsia treatment has been mostly restricted to animal models. This review aims to summarize the current data and delineate the potential future role of statins in the prevention and management of preeclampsia.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 1%
Unknown 92 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 17 18%
Researcher 10 11%
Student > Master 7 8%
Student > Doctoral Student 6 6%
Lecturer 6 6%
Other 20 22%
Unknown 27 29%
Readers by discipline Count As %
Medicine and Dentistry 45 48%
Biochemistry, Genetics and Molecular Biology 5 5%
Nursing and Health Professions 3 3%
Immunology and Microbiology 3 3%
Agricultural and Biological Sciences 3 3%
Other 3 3%
Unknown 31 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 December 2017.
All research outputs
#17,890,958
of 22,968,808 outputs
Outputs from Frontiers in Pharmacology
#7,149
of 16,248 outputs
Outputs of similar age
#221,897
of 310,732 outputs
Outputs of similar age from Frontiers in Pharmacology
#108
of 236 outputs
Altmetric has tracked 22,968,808 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,248 research outputs from this source. They receive a mean Attention Score of 5.0. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 310,732 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 236 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.